traži (Vijesti)

SLS Stock Edges Higher As Wall Street, Retail Expect Another MRNA Moment

english top health

(MENAFN - AsiaNet News) SELLAS's lead therapy, galinpepimut-S, is in a Phase 3 study called REGAL for patients with acute myeloid leukemia who are in a second complete remission. Data are due soon, ...
2026-08-19 16:45:36